The Lynx Group

Approaches to Alleviating Costs for Patients and Payers



The cost of oncology products can be ameliorated, to some extent, for payers and patients, by using imaginative reimbursement approaches. Some may involve risk shares. Some may involve other managed entry schemes that pay by outcomes. Those can help with the burden of cost for patients and payers.

Related Articles

Subscribe to
Value-Based Cancer Care

Stay up to date with personalized medicine by subscribing to recieve the free VBCC print publication or weekly e‑Newsletter.

I'd like to recieve: